PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of medicineHomeSearchSubmit a ManuscriptMedicine
 
Medicine (Baltimore). 2016 November; 95(44): e5227.
Published online 2016 November 4. doi:  10.1097/MD.0000000000005227
PMCID: PMC5591120

Physical fitness characteristics of active duty US Air Force members with HIV infection

Asha De, MD,a Xiaohe Xu, PhD,b James White, BS,b Thankam S. Sunil, PhD, MPS,b and Jason F. Okulicz, MDc,*
Monitoring Editor: Chunxiao Li.

Abstract

Human immunodeficiency virus (HIV) infection is associated with reduced muscle mass and adverse metabolic effects. We evaluated the impact of HIV infection on longitudinal exercise performance in US Air Force (USAF) members with HIV infection.

USAF members perform standardized fitness assessments every 6 to 12 months with a composite score comprised of abdominal circumference, push-ups, sit-ups, and 1.5-mile run. Fitness tests between 2004 and 2014 for male USAF members with HIV infection (n = 172) were compared with male HIV-negative controls (~10 per case; n = 1636) matched by age and rank category at service entry.

Fitness tests for cases (n = 1821) were divided into 2 groups, before (pre-HIV) and after (post-HIV) diagnosis, and compared with control fitness assessments (n = 30,443) by paired t tests. Random-effects regression analyses were also performed to compare fitness components.

Mean composite scores for cases were higher post-HIV (87.06 ± 9.10) compared with pre-HIV (84.92 ± 8.36; P = 0.004) and did not differ from respective controls. Compared with pre-HIV, mean push-up (51.50 ± 9.67 vs 50.35 ± 11.18; P = 0.018) and sit-up (51.66 ± 7.81 vs 50.57 ± 9.19; P < 0.001) counts improved post-HIV, whereas run times were similar (11:53 ± 1:42 vs 11:51 ± 2:05; P = 0.056). Regression analyses demonstrated that cases had significantly lower predicted abdominal circumference and push-up counts over time compared with controls, regardless of pre-HIV or post-HIV status (P < 0.05 for all).

Although functional limitations may occur in the setting of HIV infection, vigorous exercise performance can be both preserved and improved in HIV-infected individuals at a level comparable with HIV-uninfected persons.

Keywords: AIDS, exercise, fitness, HIV, muscle strength

1. Introduction

Life expectancy for human immunodeficiency virus (HIV) infection has significantly improved in the 3 decades after recognition of the first clinical cases of acquired immune deficiency syndrome (AIDS).[1,2] However, HIV infection remains associated with increased morbidity and impaired physical performance. Comorbid conditions are also increased in HIV-infected persons compared with those of similar age in the HIV-uninfected population.[3] In particular, HIV infection is associated with increased risk of cardiovascular disease and metabolic disturbances, including diabetes and metabolic syndrome, which can further add to physical dysfunction associated with HIV infection.[46]

There are a variety of mechanisms by which HIV infection can lead to impairments in physical function. For example, a reduction in lean muscle mass can be observed in HIV infection, which is associated with faster HIV progression, morbidity, and mortality.[79] Fat redistribution is also well-described, with loss of subcutaneous adipose tissue and gain of visceral adipose tissue, the latter which has been associated with increased cardiovascular risk and an increased 5-year, all-cause mortality in HIV-infected persons.[1013] Advanced HIV disease is often marked by impairments in both muscle strength and aerobic function.[7,14] The development of AIDS or opportunistic infections can result in a decline in physical performance due to factors such as fatigue, anorexia, dysphagia, malabsorption, muscle atrophy, and decreased habitual physical activity.[15,16] Finally, HIV-associated weight loss and wasting remains common in some patients even in the modern era of antiretroviral therapy (ART).[17]

The majority of exercise and physical performance studies in the literature have been conducted in older HIV-infected persons. In these studies, individuals with HIV infection demonstrated impairments in mild to moderate physical activity, such as reduced gait speed and 6-minute walk times, and also greater overall difficulty with other physical activities.[18,19] In contrast, studies evaluating the impact of HIV infection on vigorous exercise are limited and typically involved the implementation of short-term, structured exercise programs without longitudinal follow-up.[2022] There are no published longitudinal studies of physical fitness that include assessments of both aerobic performance and muscle strength in a population with HIV infection. The US Air Force (USAF) conducts standardized fitness assessments for all active duty members every 6 to 12 months, which evaluates body composition, muscle strength, and aerobic performance. To better understand the impact of HIV on physical performance with vigorous exercise, we evaluated longitudinal fitness characteristics for active duty USAF members with and without HIV infection.

2. Methods

USAF members have mandatory HIV testing every 2 years, or more frequently in the setting of deployment or if clinically indicated.[23] All USAF members diagnosed with HIV infection have mandatory clinical evaluations at the San Antonio Military Medical Center (SAMMC) every 6 to 12 months. The USAF manages all healthcare, travel, and lodging costs. Clinical visits include HIV disease staging, laboratory evaluation, immunizations, and HIV education. We conducted a retrospective study using physical fitness tests and data from electronic medical records collected from active duty USAF members diagnosed with HIV infection between January 1, 2004 and August 31, 2014. This retrospective study was approved by the SAMMC Institutional Review Board.

Since 2004, the standardized USAF fitness test is comprised of 4 components. Body composition is determined by measurement of abdominal circumference. Strength is assessed by the number of push-ups and sit-ups performed in 1 minute and aerobic conditioning is evaluated by a timed 1.5-mile run. A composite score (maximum = 100) is calculated by summation of the component scores for abdominal circumference (maximum score = 20), sit-ups (maximum score = 10), push-ups (maximum score = 10), and 1.5-mile run (maximum score = 60). Performance scores for each component are based on decade of age, sex, and amount of repetitions or elapsed time (available at http://www.afpc.af.mil/affitnessprogram/charts.asp). A passing composite score is ≥75 and an excellent score is ≥90. Body mass index (BMI) is also calculated, but not included in the composite score. USAF members take the standardized fitness test upon entry into military service. The frequency of subsequent fitness assessments depends upon the composite score of the most recent fitness test, with passing scores requiring testing at 6 months and excellent scores testing at 12 months. Members with physical injuries, pregnancy, or other conditions that limit the ability to take the fitness assessment are either deferred from testing or take only certain components of the test.

2.1. Study population

Inclusion criteria were male active duty USAF members with HIV infection and fitness tests between January 1, 2004 and August 31, 2014 (n = 172). Exclusion criteria were USAF members with HIV infection not on continuous active duty and females (due to small numbers). The control group was comprised of HIV-uninfected active duty USAF males matched by age and rank status (officer or enlisted) with approximately 10 controls assigned for each case (n = 1636). Composite fitness test scores, and also component scores for abdominal circumference, push-ups, sit-ups, and 1.5-mile run, were assessed. BMI was also analyzed. Tests that did not include all components of the fitness assessment were excluded for both cases and controls.

2.2. Data management

Fitness tests over time for HIV-infected cases were divided into 2 categories according to the date of HIV diagnosis. The pre-HIV time period includes all fitness tests available until the date of last known HIV-negative screening test. The post-HIV period includes all fitness assessments that occurred after the date of first positive HIV test. Fitness tests for the control group were also divided into 2 categories based on the corresponding test dates matched to the pre-HIV and post-HIV periods for cases. To evaluate the potential impact of HIV infection on physical performance, fitness assessments for cases were compared pre-HIV and post-HIV. Post-HIV cases were also analyzed by categories of CD4 cell count and viral load (VL) at or before the time of fitness tests. Cases were also compared with matched controls of the same age at the time of testing.

2.3. Statistical analysis

Characteristics were compared using simple bivariate tests. Based on Hausman test results, random-effects regression models were used to compare body composition and fitness performance with robust standard errors utilized to control for heteroscedasticity. Cross-sectional regression models were also used to compare the most recent test pre-HIV diagnosis and first test post-HIV diagnosis for cases. Analyses were performed using Stata 13, and P values <0.05 were considered statistically significant.

3. Results

A total of 172 cases with HIV infection and 1636 HIV-uninfected controls were included and contributed 1821 and 30,443 fitness tests, respectively (Table (Table1).1). For cases, the mean age at entry into military service entry was 21.2 (±3.6) years and the majority were enlisted members. The mean time from the last documented HIV-negative test to first positive test was 17.8 (±12.4) months, and the mean age at HIV diagnosis was 28.1 (±6.2) years. Among cases, the mean CD4 count and VL at HIV diagnosis was 575 (±269) cells/μL and 3.68 (±1.30) log10 copies/mL, respectively.

Table 1

Fitness test results for pre-HIV and post-HIV cases compared with controls.

Cases had a mean of 3.59 (±2.33) tests before HIV diagnosis and 7.44 (±3.71) tests after HIV diagnosis (P < 0.001). A total of 47 (27.3%) cases did not have fitness tests available before HIV diagnosis because these fitness assessments occurred before the current testing format was implemented in 2004. The largest proportion of pre-HIV tests occurred in those 18–29 years of age (75.4%), whereas post-HIV tests were similarly distributed between the 18 to 29 (46.8%) and 30 to 39 (42.9%) age categories.

3.1. Pre-HIV versus post-HIV cases

Evaluation of fitness tests for cases before and after HIV infection showed higher mean composite scores post-HIV (87.06 ± 9.10) compared with pre-HIV (84.92 ± 8.36; P = 0.004). Mean post-HIV scores were also better than pre-HIV for the components of push-up count (51.50 ± 9.67 vs 50.35 ± 11.18; P = 0.018) and sit-up count (51.66 ± 7.81 vs 50.57 ± 9.19; P < 0.001), whereas 1.5-mile run times were similar (11:53 ± 1:42 vs 11:51 ± 2:05; P = 0.056). Abdominal circumference was no different pre-HIV (32.52 ± 3.30 inches) compared with post-HIV (32.41 ± 3.15 inches; P = 0.608). There was a small increase in BMI post-HIV (25.21 ± 3.33) compared with pre-HIV (24.95 ± 3.41; P < 0.001), and the largest proportion of assessments had normal BMI (48.9% vs 58.4%, respectively).

3.2. Cases versus controls

Mean composite scores were similar for pre-HIV cases (84.92 ± 8.36) and controls (85.43 ± 9.18; P = 0.468). For mean component scores, push-up (53.04 ± 10.50 vs 50.35 ± 11.18; P = 0.001) and sit-up (52.32 ± 7.98 vs 50.57 ± 9.19; P = 0.037) counts were higher in the control group compared with the pre-HIV group, respectively, whereas run times were no different. Post-HIV mean composite scores were higher than controls (87.06 ± 9.10 vs 85.73 ± 9.55; P = 0.05), with a greater proportion achieving “excellent” scores (42.3% vs 34.9%). The post-HIV group had significantly lower mean push-up counts compared with controls (51.5 ± 9.67 vs 53.3 ± 10.36; P = 0.002). Both pre-HIV and post-HIV groups had significantly lower mean BMI and abdominal circumference values compared with their respective controls. Predicted scores by age for body composition (Fig. (Fig.1),1), and also the composite scores and individual components for muscle strength and aerobic performance (Fig. (Fig.2)2) are presented for cases and controls.

Figure 1

Adjusted body composition values by age and HIV status.

Figure 2

Adjusted fitness test performance by age and HIV status.

3.3. Regression modeling

Regression analyses of the most recent test at or before the last HIV-negative date and the first test after HIV diagnosis showed that USAF members with HIV infection had lower BMI and scored significantly lower on push-up counts than controls (Table (Table2).2). Furthermore, cases were 0.48 units lower post-HIV in the predicted abdominal circumference than controls (P < 0.01). Longitudinal fitness outcome variables evaluated by random-effects regression models (Table (Table3)3) showed no significant differences in outcomes between cases pre-HIV and post-HIV, with the exception of abdominal circumference which was 0.33 units lower post-HIV (P < 0.05) as indicated by the negative regression coefficient. Comparisons of cases and controls had several notable findings. Cases had a significantly lower predicted BMI and lower push-up counts over time than controls regardless of pre-HIV or post-HIV status, as the regression coefficients were uniformly negative and statistically significant at or below the P < 0.05 level. The predicted abdominal circumference was also 0.55 units lower over time post-HIV compared with controls (P < 0.001). Moreover, the odds of achieving an “excellent” composite score in fitness tests over time was 75.1% [(exp (0.56) = 1.75–1) × 100] higher for USAF members post-HIV than for uninfected controls.

Table 2

Cross-sectional regression models predicting body composition and performance for last fitness test pre-HIV and first fitness test post-HIV for cases compared with controls.

Table 3

Random-effects regression models predicting body composition and fitness performance with robust standard errors.

The majority of post-HIV cases had relatively preserved CD4 counts at or before fitness tests, with 90.7% having CD4 counts ≥350 cells/μL. Although data for timing of ART initiation were not available, VL suppression (<50 copies/mL) was assessed as a surrogate for effective treatment, with 56.4% of cases having VL suppression at the time of fitness testing. Regression analyses of post-HIV cases with CD4 count ≥350 vs <350 cells/μL showed no difference in composite results, individual fitness test components, or BMI. However, analyses of VL ≥50 vs <50 copies/mL showed a reduction of 2.71 units and 1.14 units for composite (P < 0.001) and “excellent” scores (P < 0.01), respectively.

4. Discussion

This study analyzed service-mandated fitness tests to assess vigorous physical exercise performance in HIV-infected USAF members. Both the longitudinal and cross-sectional results demonstrate that during a 10-year span from 2004 to 2014, USAF members with HIV had similar composite test scores compared with HIV-uninfected controls. These results suggest that impaired physical fitness is not a barrier to continuing military service for USAF members with HIV infection. Interestingly, we observed improved performance in several test components after HIV diagnosis, which suggests that members may have increased their physical conditioning as part of improved health-seeking behaviors.

Despite advances in medical therapy, physical and functional limitations are commonly observed in HIV-infected populations. For example, HIV infection can be complicated by skeletal muscle wasting, particularly metabolically active lean tissue, which has been associated with increased all-cause mortality and accelerated disease progression.[2426] In a study of over 900 patients with skeletal muscle and adipose tissue assessments by magnetic resonance imaging, lower muscle mass was independently associated with an increased risk of mortality.[12] USAF fitness tests assessed muscle strength by timed push-ups and sit-ups. Although muscle strength was statistically lower post-HIV compared with controls, both push-up and sit-up counts were also statistically lower pre-HIV compared with controls. The availability of preinfection fitness test data was essential because analyses demonstrated that these characteristics were present before HIV infection and thus eliminated HIV as the explanation for lower muscle strength compared with controls. In addition, cases improved muscle strength after HIV infection as demonstrated by statistically higher push-up and sit-up counts compared with pre-HIV values. These results suggest that HIV-associated reduction in muscle strength is either not present in a population or can be mitigated by improved physical conditioning.

HIV infection is also associated with decreased exercise and activity tolerance. For example, 1 study observed a decrease in peak aerobic capacity with 6-minute walk test results below the age-specific threshold in 24% of HIV-infected individuals.[27] While not as commonly noted in activities of daily living, limitations are particularly evident in vigorous activities ranging from 8% of asymptomatic individuals to 58% of persons with AIDS.[19,28] Even in those on ART, limitations in oxygen delivery to muscles during exercise have been noted with an approximate decrease of 70% of maximum predicted maximal oxygen uptake and significantly lower lactic acid thresholds.[29] Although functional data, such as oxygen delivery and uptake, were not specifically measured in our study, performance on the 1.5-mile run component of the fitness test can serve as a surrogate for these assessments. USAF members performed the 1.5-mile run in approximately 12 minutes, and these values did not differ pre-HIV or post-HIV, or when compared with controls. It is possible that functional limitations may be minor or unapparent in HIV-infected persons who perform regular vigorous exercise and maintain a high level of physical conditioning before HIV infection.

There are several possible explanations as to why HIV infection did not seem to substantially impact exercise performance in our study in contrast to other studies. For example, most published studies are not directly comparable since mild to moderate physical activity endpoints, such as 6-minute walk, chair rise time, and gait speed, were evaluated.[18,19] Studies involving vigorous activities are limited, and usually involved structured exercise programs in persons without a high level of physical conditioning before study entry.[14,20,22] This is in contrast to the USAF population who were required to continually maintain fitness standards. Patient characteristics such as advanced HIV disease with AIDS and/or low CD4 counts have been associated with impairments in both muscle strength and aerobic function.[7,14,30] However, USAF members are typically diagnosed early due to mandated HIV testing with relatively preserved CD4 counts, and we did not observe differences in exercise performance for those with CD4 counts below 350 cells/μL. Lower composite and “excellent” scores were observed for persons with nonsuppressed VLs (≥50 copies/mL). This most likely represents the subgroup which had not initiated ART since VL suppression is high (>90%) for those on ART in our population.[31] This presumed lack of ART use may be a marker for reduced interest in personal health or health-seeking behaviors in this subgroup compared with our overall population, which may account for these findings. Other studies evaluating the impact of effective ART on fitness performance have been variable, with several studies showing no impact on aerobic performance or cardiac function.[32,33] In addition, we did not observe any differences in fitness outcomes when comparing fitness tests directly before and after HIV infection, when members were either ART-naïve or recently started on ART, which suggests that other nonmeasured factors may be involved.

Since exercise performance can diminish with age, the younger age of our USAF population is an important feature of our study compared with the predominance of older individuals in other studies. For example, 1 study showed greater loss of physical function in those with HIV infection compared with uninfected persons; however, the median age was 50 years.[34] This is in contrast to our USAF population who had a mean age of 28 years at HIV diagnosis. Interestingly, the younger age group (age ≤44 years) of HIV-infected individuals in this study reported higher physical function than those without HIV infection, and this was the only age group to report similar frequency of exercise compared with HIV-uninfected persons. This raises the question of whether physical inactivity may play a larger role in study outcomes than physical limitations attributed to HIV infection. Physical inactivity may be a significant confounder as 1 study observed that fewer HIV-infected persons met US Department of Health and Human Services Healthy People 2010 physical activity recommendations than persons in the general population.[35] Since our USAF population is required to maintain fitness, it is possible that HIV infection minimally impacts physical function in persons with higher levels of physical conditioning at the time of HIV acquisition.

This study is the first to evaluate longitudinal physical fitness assessments in HIV-infected persons. Study strengths include the availability of preinfection data and the evaluation of multicomponent standardized fitness tests that assessed both muscle strength and aerobic function in both cases and controls spanning an entire decade. Limitations include the retrospective study design and inability to assess additional aspects of ART use including potential differences in fitness by use of specific treatment regimens and timing of ART initiation. Data for comorbid conditions were also unavailable. Behaviors that may have impacted physical performance, such as routine exercise habits, smoking, and diet, were not captured as part of the standardized fitness assessment.

The benefits of physical activity in the HIV-infected population have been well-documented. Progressive resistive exercise in HIV-infected individuals resulted in improvement in weight, body composition, and lean muscle mass, and a 6-month aerobic and resistance exercise program resulted in decreased heart rate in participants.[10,22,36] Exercise has also been associated with improved cognition with reduced impairments of working memory and speed of information processing.[22,37] Participation in a regular exercise program has also been shown to improve self-efficacy, mood, and fatigue resulting in higher life-satisfaction scores in HIV-infected individuals.[22,3840] The results of our study show that a high level of exercise performance can be both preserved and improved in individuals with HIV, allowing them to gain the benefits of continued physical exercise despite potential limitations of the disease process. Providers should continue to encourage participation in regular physical activity due to the physical, mental, and emotional benefits of exercise observed in HIV-infected patients.

Footnotes

Abbreviations: AIDS = acquired immune deficiency syndrome, ART = antiretroviral therapy, BMI = body mass index, HIV = human immunodeficiency virus, SAMMC = San Antonio Military Medical Center, USAF = United States Air Force, VL = viral load.

Funding disclosures: There is no funding source for this study. The views expressed herein are those of the authors and do not reflect the official policy or position of San Antonio Military Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of the Air Force, the Department of Defense, or the U.S. Government.

The authors report no conflicts of interest.

References

1. Legarth RA, Ahlstrom MG, Kronborg G, et al. Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study. J Acquir Immune Defic Syndr 2016; 71:213–218. [PubMed]
2. Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013; 56:727–734. [PubMed]
3. Schouten J, Wit FW, Stolte IG, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 2014; 59:1787–1797. [PubMed]
4. Longenecker CT, Sullivan C, Baker JV. Immune activation and cardiovascular disease in chronic HIV infection. Curr Opin HIV AIDS 2016; 11:216–225. [PMC free article] [PubMed]
5. Tripathi A, Liese AD, Jerrell JM, et al. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time. Diabet Med 2014; 31:1185–1193. [PubMed]
6. Capeau J, Bouteloup V, Katlama C, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS 2012; 26:303–314. [PubMed]
7. Grinspoon S, Corcoran C, Rosenthal D, et al. Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab 1999; 84:201–206. [PubMed]
8. Guenter P, Muurahainen N, Simons G, et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr 1993; 6:1130–1138. [PubMed]
9. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:80–85. [PubMed]
10. Bacchetti P, Gripshover B, Grunfeld C, et al. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 2005; 40:121–131. [PMC free article] [PubMed]
11. Cofrancesco J, Jr, Freedland E, McComsey G. Treatment options for HIV-associated central fat accumulation. AIDS Patient Care STDS 2009; 23:5–18. [PubMed]
12. Scherzer R, Heymsfield SB, Lee D, et al. Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection. AIDS 2011; 25:1405–1414. [PMC free article] [PubMed]
13. Grinspoon S. Diabetes mellitus, cardiovascular risk, and HIV disease. Circulation 2009; 119:770–772. [PubMed]
14. Stringer WW. Mechanisms of exercise limitation in HIV+ individuals. Med Sci Sports Exerc 2000; 32:S412–421. [PubMed]
15. Smit E, Crespo CJ, Semba RD, et al. Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care 2006; 18:1040–1045. [PubMed]
16. de Pee S, Semba RD. Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food Nutr Bull 2010; 31:S313–344. [PubMed]
17. Tang AM, Jacobson DL, Spiegelman D, et al. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. J Acquir Immune Defic Syndr 2005; 40:70–76. [PubMed]
18. Erlandson KM, Allshouse AA, Jankowski CM, et al. Relationship of physical function and quality of life among persons aging with HIV infection. AIDS 2014; 28:1939–1943. [PMC free article] [PubMed]
19. Oursler KK, Goulet JL, Leaf DA, et al. Association of comorbidity with physical disability in older HIV-infected adults. AIDS Patient Care STDS 2006; 20:782–791. [PubMed]
20. Garcia A, Fraga GA, Vieira RC, Jr, et al. Effects of combined exercise training on immunological, physical and biochemical parameters in individuals with HIV/AIDS. J Sports Sci 2014; 32:785–792. [PubMed]
21. Stringer WW. HIV and aerobic exercise. Current recommendations. Sports Med 1999; 28:389–395. [PubMed]
22. Fillipas S, Oldmeadow LB, Bailey MJ, et al. A six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial. Aust J Physiother 2006; 52:185–190. [PubMed]
23. Kugblenu RK, Paulin PS, Tastad KJ, et al. HIV testing patterns for United States Air Force personnel, 2008–2012. Public Health 2016; 133:91–98. [PubMed]
24. Smit E, Skolasky RL, Dobs AS, et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection 1987–1999. Am J Epidemiol 2002; 156:211–218. [PubMed]
25. Grinspoon S, Mulligan K. Department of Human Services Working Group on the P, Treatment of W, Weight L. Weight loss and wasting in patients infected with human immunodeficiency virus. Department of H, Human Services Working Group on the P, Treatment of W, Weight L. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 2003; 36:S69–78. [PubMed]
26. Szulc P, Munoz F, Marchand F, et al. Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study. Am J Clin Nutr 2010; 91:1227–1236. [PubMed]
27. Richert L, Dehail P, Mercie P, et al. High frequency of poor locomotor performance in HIV-infected patients. AIDS 2011; 25:797–805. [PubMed]
28. Fleishman JA, Crystal S. Functional status transitions and survival in HIV disease: evidence from the AIDS Costs and Service Utilization Survey. Med Care 1998; 36:533–543. [PubMed]
29. Johnson JE, Slife DM, Anders GT, et al. Cardiac dysfunction in patients seropositive for the human immunodeficiency virus. West J Med 1991; 155:373–379. [PMC free article] [PubMed]
30. Arey BD, Beal MW. The role of exercise in the prevention and treatment of wasting in acquired immune deficiency syndrome. J Assoc Nurses AIDS Care 2002; 13:29–49. [PubMed]
31. Matthews PE, Le T, Delmar J, et al. Virologic suppression among HIV-infected US Air Force members in a highly-structured programme with free access to care. Int J STD AIDS 2015; 26:951–959. [PubMed]
32. Cade WT, Fantry LE, Nabar SR, et al. Impaired oxygen on-kinetics in persons with human immunodeficiency virus are not due to highly active antiretroviral therapy. Arch Phys Med Rehabil 2003; 84:1831–1838. [PubMed]
33. Hand GA, Phillips KD, Dudgeon WD, et al. Moderate intensity exercise training reverses functional aerobic impairment in HIV-infected individuals. AIDS Care 2008; 20:1066–1074. [PubMed]
34. Oursler KK, Goulet JL, Crystal S, et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS 2011; 25:13–20. [PMC free article] [PubMed]
35. Clingerman EM. Participation in physical activity by persons living with HIV disease. J Assoc Nurses AIDS Care 2003; 14:59–70. [PubMed]
36. O’Brien K, Tynan AM, Nixon S, et al. Effects of progressive resistive exercise in adults living with HIV/AIDS: systematic review and meta-analysis of randomised trials. AIDS Care 2008; 20:631–653. [PubMed]
37. Dufour CA, Marquine MJ, Fazeli PL, et al. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. J Neurovirol 2013; 19:410–417. [PMC free article] [PubMed]
38. Lox CL, McAuley E, Tucker RS. Physical training effects on acute exercise-induced feeling states in HIV-1-positive individuals. J Health Psychol 1996; 1:235–240. [PubMed]
39. Agin D, Gallagher D, Wang J, et al. Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV. AIDS 2001; 15:2431–2440. [PubMed]
40. Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366:378–384. [PubMed]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health